Buendía-Roldán I - Search Results

1

CX3CL1 and CX3CR1 could be a relevant molecular axis in the pathophysiology of idiopathic pulmonary fibrosis.

Rivas-Fuentes S, Herrera I, Salgado-Aguayo A, Buendía-Roldán I, Becerril C, Cisneros J. Rivas-Fuentes S, et al. Int J Med Sci. 2020 Aug 29;17(15):2357-2361. doi: 10.7150/ijms.43748. eCollection 2020. Int J Med Sci. 2020. PMID: 32922201 Free PMC article.

2

Risk factors for idiopathic pulmonary fibrosis in a Mexican population. A case-control study.

García-Sancho Figueroa MC, Carrillo G, Pérez-Padilla R, Fernández-Plata MR, Buendía-Roldán I, Vargas MH, Selman M. García-Sancho Figueroa MC, et al. Respir Med. 2010 Feb;104(2):305-9. doi: 10.1016/j.rmed.2009.08.013. Epub 2009 Sep 25. Respir Med. 2010. PMID: 19782552 Free article.

3

Familial pulmonary fibrosis is the strongest risk factor for idiopathic pulmonary fibrosis.

García-Sancho C, Buendía-Roldán I, Fernández-Plata MR, Navarro C, Pérez-Padilla R, Vargas MH, Loyd JE, Selman M. García-Sancho C, et al. Respir Med. 2011 Dec;105(12):1902-7. doi: 10.1016/j.rmed.2011.08.022. Epub 2011 Sep 13. Respir Med. 2011. PMID: 21917441 Free article.

4

Fibrocytes contribute to inflammation and fibrosis in chronic hypersensitivity pneumonitis through paracrine effects.

García de Alba C, Buendia-Roldán I, Salgado A, Becerril C, Ramírez R, González Y, Checa M, Navarro C, Ruiz V, Pardo A, Selman M. García de Alba C, et al. Am J Respir Crit Care Med. 2015 Feb 15;191(4):427-36. doi: 10.1164/rccm.201407-1334OC. Am J Respir Crit Care Med. 2015. PMID: 25531246

5

Serum surfactant protein D (SP-D) is a prognostic marker of poor outcome in patients with A/H1N1 virus infection.

Delgado C, Krötzsch E, Jiménez-Alvarez LA, Ramírez-Martínez G, Márquez-García JE, Cruz-Lagunas A, Morán J, Hernández C, Sierra-Vargas P, Avila-Moreno F, Becerril C, Montaño M, Bañales-Méndez JL, Zúñiga J, Buendía-Roldán I. Delgado C, et al. Lung. 2015 Feb;193(1):25-30. doi: 10.1007/s00408-014-9669-3. Epub 2014 Dec 24. Lung. 2015. PMID: 25537934 Free PMC article.

6

Aging and Pulmonary Fibrosis.

Selman M, Buendía-Roldán I, Pardo A. Selman M, et al. Rev Invest Clin. 2016 Mar-Apr;68(2):75-83. Rev Invest Clin. 2016. PMID: 27103043 Free article. Review.

7

Increased Expression of CC16 in Patients with Idiopathic Pulmonary Fibrosis.

Buendía-Roldán I, Ruiz V, Sierra P, Montes E, Ramírez R, Vega A, Salgado A, Vargas MH, Mejía M, Pardo A, Selman M. Buendía-Roldán I, et al. PLoS One. 2016 Dec 15;11(12):e0168552. doi: 10.1371/journal.pone.0168552. eCollection 2016. PLoS One. 2016. PMID: 27977812 Free PMC article.

8

Idiopathic pulmonary fibrosis: Clinical behavior and aging associated comorbidities.

Buendía-Roldán I, Mejía M, Navarro C, Selman M. Buendía-Roldán I, et al. Respir Med. 2017 Aug;129:46-52. doi: 10.1016/j.rmed.2017.06.001. Epub 2017 Jun 3. Respir Med. 2017. PMID: 28732835 Free article. Review.

9

Transmembrane protease, serine 4 (TMPRSS4) is upregulated in IPF lungs and increases the fibrotic response in bleomycin-induced lung injury.

Valero-Jiménez A, Zúñiga J, Cisneros J, Becerril C, Salgado A, Checa M, Buendía-Roldán I, Mendoza-Milla C, Gaxiola M, Pardo A, Selman M. Valero-Jiménez A, et al. PLoS One. 2018 Mar 12;13(3):e0192963. doi: 10.1371/journal.pone.0192963. eCollection 2018. PLoS One. 2018. PMID: 29529050 Free PMC article.

10

Identification of MMP28 as a biomarker for the differential diagnosis of idiopathic pulmonary fibrosis.

Maldonado M, Buendía-Roldán I, Vicens-Zygmunt V, Planas L, Molina-Molina M, Selman M, Pardo A. Maldonado M, et al. PLoS One. 2018 Sep 12;13(9):e0203779. doi: 10.1371/journal.pone.0203779. eCollection 2018. PLoS One. 2018. PMID: 30208119 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

100 results

Search Page